Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00921_DB01367> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00921_DB01367 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00921_DB01367 label "DDI between Buprenorphine and Rasagiline - Buprenorphine may enhance the adverse/toxic effect of MAO Inhibitors like rasagiline. When possible, avoid use of buprenorphine in patients who have used a monoamine oxidase inhibitor within the past 14 days due to possible severe adverse effects. [drugbank_resource:DB00921_DB01367]" assertion.
- drugbank_resource:DB00921_DB01367 identifier "drugbank_resource:DB00921_DB01367" assertion.
- drugbank_resource:DB00921_DB01367 title "DDI between Buprenorphine and Rasagiline - Buprenorphine may enhance the adverse/toxic effect of MAO Inhibitors like rasagiline. When possible, avoid use of buprenorphine in patients who have used a monoamine oxidase inhibitor within the past 14 days due to possible severe adverse effects." assertion.